Literature DB >> 7201581

Familial myoadenylate deaminase deficiency and exertional myalgia.

J Kelemen, D R Rice, W G Bradley, T L Munsat, S DiMauro, E L Hogan.   

Abstract

In 14 members of four families with a hereditary syndrome of exertional myalgia, five of eight muscle biopsies from symptomatic individuals showed histochemical and biochemical absence of myoadenylate deaminase (MADA). In the others, MADA biochemical activity was normal in two and reduced but not absent (intermediate level) in one. Asymptomatic relatives had normal histochemical MADA activity, but three had intermediate biochemical levels. In a survey of 302 routine muscle biopsies, 3 of 36 patient with myalgia had absence of MADA. Three of 266 biopsied for other conditions were MADA-deficient. Despite some inconsistencies, MADA deficiency seems to be relevant to this clinical syndrome.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201581     DOI: 10.1212/wnl.32.8.857

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.

Authors:  M A Tarnopolsky; G Parise; M J Gibala; T E Graham; J W Rush
Journal:  J Physiol       Date:  2001-06-15       Impact factor: 5.182

2.  [Diagnostic significance of muscle biopsies in metabolic myopathies. II. Clinical biochemistry].

Authors:  T Deufel; I Paetzke; D Pongratz; G Hübner; O H Wieland
Journal:  Klin Wochenschr       Date:  1984-07-16

Review 3.  Myoadenylate deaminase deficiency.

Authors:  H H Goebel; A Bardosi
Journal:  Klin Wochenschr       Date:  1987-11-02

4.  Molecular basis of AMP deaminase deficiency in skeletal muscle.

Authors:  T Morisaki; M Gross; H Morisaki; D Pongratz; N Zöllner; E W Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

5.  Myopathic evolution of an exertional muscle pain syndrome with phosphorylase b kinase deficiency.

Authors:  H Carrier; I Maire; C Vial; G Rambaud; F Flocard; A Flechaire
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Respiratory failure as initial symptom of acid maltase deficiency.

Authors:  R W Keunen; P C Lambregts; A A Op de Coul; E M Joosten
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

Review 7.  Molecular biology of AMP deaminase deficiency.

Authors:  M Gross
Journal:  Pharm World Sci       Date:  1994-04-15

8.  Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect.

Authors:  H Morisaki; T Morisaki; L K Newby; E W Holmes
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.

Authors:  R L Sabina; J L Swain; C W Olanow; W G Bradley; W N Fishbein; S DiMauro; E W Holmes
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

10.  Myoadenylate deaminase deficiency: absence of correlation with exercise intolerance in 452 muscle biopsies.

Authors:  R Mercelis; J J Martin; T de Barsy; G Van den Berghe
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.